Fig. 7
From: Claudin-4-adhesion signaling drives breast cancer metabolism and progression via liver X receptor β
The "CLDN4-high/LXRβ-high" TNBC cases exhibit poor prognosis. A Immunohistochemical staining of CLDN4 and LXRβ in breast cancer tissues. Four representative patterns are presented depending on the expression levels of CLDN4 and LXRβ. HE, hematoxylin–eosin. Scale bar, 100 µm. B The overall and recurrence-free survival in "CLDN4-high/LXRβ-high" and "CLDN4-low and/or LXRβ-high" groups of the indicated breast cancer subjects